[Transfusional therapy of hemodialyzed patient with anti-Cartwright antibodies: case report and review of the literature].
BACKGROUND
Red cell Cartwright antigen (Yta) is very common in the general population therefore patients without red cell Cartwright antigen and with anti-Yta alloantibodies due to previous exposure to the antigen are rare. Report about clinical significance of Yta red cell alloantibodies in hemodialysis (HD) patients are scarce.


METHODS
We report a cirrhotic uremic patient with anti-Yta antibodies who received Yta positive red cells. No adverse reactions nor hemolysis were detected.


CONCLUSIONS
We concluded that dialysis patients with anti-Yta antibodies could be safely transfused with blood from Cartwright positive donors.
Franchini
M
M
Servizio di Immunoematologia e Trasfusione, Ospedale Civile Maggiore, Verona.
Fabbian
F
F
Piccoli
P L
PL
Gandini
G
G
Aprili
G
G
Loschiavo
C
C
Lupo
A
A
D000328:Adult; D001803:Blood Transfusion; D004912:Erythrocytes / Q000276:immunology*; D006801:Humans; D007518:Isoantibodies / Q000097:blood*; D007519:Isoantigens / Q000276:immunology*; D008297:Male; D006435:Renal Dialysis; D014511:Uremia / Q000097:blood* / Q000628:therapy*
D007518:Isoantibodies; D007519:Isoantigens